Creso Pharma
- Short interest
- 0.06%
- −0.01 pp 30d
- as of 8 June 2023
- Reported shorts
- 1.6M
- Shares on issue
- 2.567B
Creso Pharma (CPH) Short Interest
Creso Pharma (ASX:CPH) had 0.06% of shares reported as short positions as of 8 June 2023, representing 1,624,075 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Creso Pharma
Creso Pharma is an ASX-listed pharmaceutical company focused on the development and commercialization of innovative therapeutic products. The company aims to address unmet medical needs through its research and development pipeline, potentially leveraging novel drug delivery systems or active pharmaceutical ingredients. Its market position is likely within niche therapeutic areas, striving for differentiation through scientific innovation and clinical efficacy.
Company profile →Creso Pharma (ASX:CPH) has 0.06% of its shares on issue reported as short positions as of 8 June 2023, or about 1,624,075 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 1.42% in July 2021. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Company details
website
Be the first to discuss CPH
Start a research thread or post the first pulse update